Ind-Swift, Wockhardt launch generic Lipitor in UK - Reuters India

REUTERS - Drugmakers Ind-Swift (INSW.NS) and Wockhardt (WCKH.NS) have jointly launched a generic version of Pfizer's (PFE.N) cholesterol lowering drug Lipitor in the United Kingdom, the two companies said. The copycat version was launched on the ...

India's Ind-Swift, Wockhardt launch generic Lipitor in UK - Reuters

May 17 (Reuters) - Indian drugmakers Ind-Swift and Wockhardt have jointly launched a generic version of Pfizer's cholesterol lowering drug Lipitor in the United Kingdom, the two companies said. The copycat version was launched on the first day ...

Charges, generic Lipitor cut Pfizer Q1 net 19 pct - Yahoo Finance

Pfizer Inc.'s first-quarter profit fell 19 percent, because of legal and other charges and new generic competition to blockbuster cholesterol pill Lipitor that cut the drugmaker's U.S. sales by 15 percent. The world's biggest drugmaker beat Wall ...

Atorvastatin Lifts Ranbaxy While Pfizer Abandons Its Lipitor Marketing Efforts - Forbes

Pfizer will no longer aggressively market Lipitor (atorvastatin), its former crown jewel and the most lucrative pharmaceutical product ever. At the same time, generic drug manufacturer Ranbaxy posted record revenue for the last business quarter ...

Mylan now selling generic Lipitor in Europe - Yahoo Finance

PITTSBURGH (AP) -- Mylan Inc. said Friday that it is selling a low-cost generic version of the cholesterol drug Lipitor in five European countries. Mylan said it is selling its generic version in the U.K., Ireland, France, Belgium and the ...

Ranbaxy Q1 profit jumps on generic Lipitor - in.news.yahoo.com

REUTERS - Ranbaxy Laboratories, India's top drugmaker by sales, reported a four-fold rise in quarterly net profit, helped by sales of its generic version of cholesterol drug Lipitor in its key U.S. market, sending its shares up more than 4.5 percent.

New Generics Soon Available for Best-Selling Drug Lipitor - Newswise

Newswise — (St. Louis)- In just days, a number of generic versions of Lipitor will hit pharmacy shelves. Pfizer’s 180-day generic exclusivity agreement for the medication expires at the end of the month. That will bring a host of new generic ...

Lipitor marketing reaches the end of the road - PRWeek

Pfizer is giving up the ghost when it comes to promoting cholesterol drug Lipitor in the US. The patent on the drug expired November 30 of last year. Pfizer had touted the drug through its "Lipitor for You" program, which provided consumers with a co-pay ...

ED GOLDMAN: Lipitor and more - The Business Journal

Quibbles and Obits — An Associated Press story last Wednesday about the probable causes of painter Thomas Kinkade’s death — alcohol and drugs — might have shown that the venerable news service endorses a belief in the afterlife.

Lipitor copy powers a surge in Ranbaxy sales, profits - FiercePharma

What a difference generic Lipitor can make. Ranbaxy Laboratories' first-quarter earnings soared on its launch of the cholesterol drug copycat, to 12.47 billion rupees--$234.3 million--from 3.04 billion rupees last year. The numbers also beat ...